Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Titel:
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Auteur:
Westphal, Manfred Ylä-Herttuala, Seppo Martin, John Warnke, Peter Menei, Philippe Eckland, David Kinley, Judith Kay, Richard Ram, Zvi